IRMD
IRadimed CorporationHealthcare · $1.1B market cap
Verdict
Share price
$85.40
close of Oct 3, 2026
Fair value
$40.07
Sticker Price
Payback Price
$16.03
buy price
IRMD is Overpriced: at $85.40 it trades 113% above its fair value of $40.07. Its buy price (Payback Price) is $16.03, 81% below today's price. Business quality is strong: all 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
5 of 5 clear the 10% bar. What are the Big Five?
Follow IRMD
Get notified when it reaches its buy price of $16.03. Free.
Create a free accountSuperinvestors
None of the investors we track holds IRMD right now. In Q2 2026, 1 sold out. Who we track
Moves in Q2 2026
Sold out: Polen Capital Management
Insider activity
Since Jun 20, 2026: no open-market purchases, 2 sales worth $123K and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Other filings
About IRadimed Corporation
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works